Biotech NewsIs Apimeds (APUS) the Most Undervalued Small-Cap Biotech? BioTech Health XNovember 16, 2025 Apimeds Pharmaceuticals US Inc. (NYSE:APUS) is a clinical-stage biopharmaceutical company built on a mission to transform pain management… 0 Shares 0 0 0 0 0 0 0